New research has shown that, contrary to some previous studies, low levels of lipoprotein (a) – a parcel of fats and protein in the blood – do not cause type 2 diabetes. The findings may alleviate ...
Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.
If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...
Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected ...
Go to source). This means even healthy individuals can have elevated levels without obvious risk factors. Many people remain unaware of their levels because routine tests do not always include it.
A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...
Heart experts say that everyone should have their levels of lipoprotein (a), or Lp(a), measured routinely at least once in life, following research from one of the most populous EU countries, Poland, ...
Most people know about “good” and “bad” cholesterol. But few realise there is another type called lipoprotein(a). It can raise the risk of heart attacks and strokes, even in people who do everything ...
The joint document, published simultaneously in the journals JACC and Circulation, addresses not just cholesterol, but a full range of blood lipids that contribute to atherosclerosis — the buildup of ...
Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on ...
The combination of high triglycerides and low high-density lipoprotein (HDL) cholesterol can arise from physical inactivity, drinking too much alcohol, and obesity. It can lead to serious health ...